GSK Sells Indian Site To Hetero Labs

Company Strikes $25m Deal For Manufacturing Plant In Vemgal, Karnataka

GSK has sold its Vemgal manufacturing plant to Indian company Hetero Labs. GSK’s decision came after the recall of ranitidine products made in India.

sold property sign
GSK sells Karnataka plant to India’s Hetero Labs • Source: Shutterstock

More from Deals

More from Business